The secretion of pro-inflammatory cytokines |
CAFs and TAMs |
Induces inflammation |
CAFs and TAMs secrete IL-6 and TNF-α, which can foster chronic inflammation, paradoxically promoting tumor progression. |
The secretion of immunosuppressive factors |
CAFs and TAMs |
Immunosuppression |
CAFs and TAMs secrete TGF-β, IL-10, and PD-L1, which inhibit T cells and promote Tregs. |
T cell exhaustion |
T cells |
Immunosuppression |
Chronic exposure to tumor antigens and inflammatory signals can lead to a state of T cell dysfunction characterized by sustained expression of inhibitory receptors (PD-1 and CTLA-4). |
The recruitment of regulatory immune cells |
MDSCs and Tregs |
Immunosuppression |
The tumor stroma can attract immunosuppressive cell types like MDSCs and Tregs, which suppress cytotoxic T cells and NK cells. |
Metabolic reprogramming |
Tumor cells and stromal cells |
Immunosuppression |
Tumor cells and stromal cells can alter the metabolic landscape of the TME, creating conditions like hypoxia and nutrient deprivation that negatively impact immune cell function. |
The modulation of extracellular matrix (ECM) |
CAFs |
Creates a physical barrier |
CAFs can remodel the ECM, creating a physical barrier that hinders immune cell infiltration and access to tumor cells. |
Cell polarization |
TAMs, CD4+ T cells, MDSCs, and DCs |
Immunosuppression |
TAMs adopt an M2 polarization state, CD4+ T cells can be polarized into Tregs, MDSCs suppress T cell function, and DCs can become tolerogenic. |